Clinical trial
A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease
NCT01442363 is registered in ClinicalTrials.gov with Braintree Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease
- Lead sponsor
- Braintree Laboratories
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2011
- Completion date
- October 31, 2012
- Enrollment
- 4 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
perianal crohn's disease